RT Journal Article
SR Electronic
A1 Vinall, Phil
T1 Results of the COMET Trial
JF MD Conference Express
YR 2008
FD SAGE Publications
VO 8
IS 5
SP 13
OP 14
DO 10.1177/155989770800800506
UL http://mdc.sagepub.com/content/8/5/13.2.abstract
AB This article discusses the initial 52-week data from the COMET trial which showed that etanercept in combination with methotrexate (MTX) was superior to MTX alone in providing clinical remission, radiographic non-progression, and normalized function.